# POSACONAZOLE
> **ANDA207355** · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS FL INC · Approved 2022-11-30
## Drug
- **FDA Application Number:** ANDA207355
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** POSACONAZOLE
- **Generic name:** Posaconazole
- **Active ingredients:** POSACONAZOLE
- **Dosage form:** TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ACTAVIS LABS FL INC
- **First approval:** 2022-11-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207355)
---
*MORVS · CC0 1.0*